Biochemical markers of bone turnover. A look at laboratory tests that reflect bone status

Postgraduate Medicine

Volumn 104, Issue 4, 1998, Pages

  Rosen, Clifford J ^a   Tenenhouse, Alan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

BONE ATROPHY; BONE REMODELING; BONE TURNOVER; CONFERENCE PAPER; DENSITOMETRY; HUMAN; LABORATORY DIAGNOSIS; OSSIFICATION; OSTEOPOROSIS;

EID: 7844248653     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.10.447     Document Type: Conference Paper

References (23)

1. Albright FA. Postmenopausal osteoporosis. JAMA 1941;116: 2465-74
2. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332(5):305-11
3. Rosen CJ. Biochemical markers of bone turnover. In: Rosen CJ, ed. Osteoporosis: diagnostic and therapeutic principles. Totowa, NJ: Humana Press, 1996:129-41
4. Kelly PJ, Pocock NA, Sambrook PN, et al. Age- and menopause-related changes in indices of bone turnover. J Clin Endocrinol Metab 1989;69(6):1160-5
5. Jodar Gimeno E, Munoz-Torres M, Escobar-Jimenez F, et al. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: role of biological markers of bone turnover. Calcif Tissue Int 1997;61(5):370-6
6. Seibel MJ, Gartenberg F, Silverberg SJ, et al. Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 1992;74(3):481-6
7. Christiansen C, Riis BJ, Rodbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987;1(8542):1105-8
8. Seibel MJ, Cosman F, Shen V, et al. Urinary hydroxypyridinium cross-links of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1993;8(7): 881-9
9. Garnero P, Sornay-Rendu E, Chapuy MC, et al. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;11(3):337-49
10. Johansen JS, Riis BJ, Delmas PD, et al. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 1988;18(2):191-5
11. Slemenda C, Hui SL, Longcope C, et al. Sex steroids and bone mass: a study of changes about the time of menopause. J Clin Invest 1987;80(5):1261-9
12. Rosen CJ, Chesnut CH 3d, Mallinak NJ. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab 1997;82(6): 1904-10
13. Civitelli R, Gonnelli S, Zacchei F, et al. Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment. J Clin Invest 1988;82(4):1268-74
14. Ensrud KE, Palermo L, Black DM, et al. Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res 1995;10(11): 1778-87
15. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 1996;11(10):1531-8
16. Chapuy MC, Schott AM, Garnero P, et al, for the EPIDOS Study Group. Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 1996;81(3):1129-33
17. Rosen CJ, Morrison A, Zhou H, et al. Elderly women in northern New England exhibit seasonal changes in bone mineral density and calciotropic hormones. Bone Miner 1994;25(2):83-92
18. Riis BJ, Overgaard K, Christiansen C. Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy. Osteoporos Int 1995;5(4):276-80
19. Garnero P, Shih WJ, Gineyts E, et al. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79(6):1693-700
20. Kraenzlin ME, Seibel MJ, Trechsel U, et al. The effect of intranasal salmon calcitonin on postmenopausal bone turnover as assessed by biochemical markers: evidence of maximal effect after 8 weeks of continuous treatment. Calcif Tissue Int 1996;58(4):216-20
21. Cheung CK, Panesar NS, Lau E, et al. Increased bone resorption and decreased bone formation in Chinese patients with hip fracture. Calcif Tissue Int 1995;56(5):347-9
22. Garnero P, Gineyts E, Arbault P, et al. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995;10(4):641-9
23. Gertz BJ, Shao P, Hanson DA, et al. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 1994; 9(2):135-42